Capienda is developing an advanced system (novel assay chemistry + bioanalytical instrument) to accelerate drug discovery in the pharmaceutical industry.
METHODS AND SYSTEMS FOR HIGH-THROUGHPUT KINETIC ANALYSIS OF LIGAND-RECEPTOR INTERACTIONS
US Patent Applications 63/676,831 and 63/765,075.
Capienda’s drug delivery technology is designed to target disease-relevant cells (while avoiding normal cells) and engages previously un-druggable targets.
COMPOSITIONS AND METHODS FOR TREATING INFLAMMATORY DISEASES. PCT/US2019/025,207.